Psychiatric Symptoms in Patients With Metastatic ALK-Positive NSCLC Treated With Third-Generation ALK-Inhibitors: A Brief Review and Case Series. JMS 2024, 93 (3), e986. https://doi.org/10.20883/medical.e986.